Skip to content
BiologicalX

Comparison

Spermidine vs Tirzepatide

Side-by-side of Spermidine and Tirzepatide. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Spermidine

  • Endogenous polyamine that induces autophagy via EP300 acetyltransferase inhibition and TFEB activation
  • Concentrated in wheat germ, soybeans, aged cheese, and mushrooms; ~10 to 15 mg/day in Mediterranean diets
  • Eisenberg 2016 reported dietary spermidine extended mouse lifespan and improved cardiac function
  • Wirth 2018 pilot (n=28) reported cognitive signal at 0.9 mg/day in older adults at risk for dementia
  • Larger Wirth 2019 follow-up (n=85) did not replicate the memory benefit at 12 months
  • Generally regarded as safe at supplemental doses; food-source position is reassuring

Tirzepatide

  • Dual GIP plus GLP-1 receptor agonist with a ~5-day half-life supporting once-weekly subcutaneous dosing
  • SURMOUNT-1 reported ~22.5% mean body-weight loss at 15 mg over 72 weeks versus 2.4% on placebo
  • Lowers HbA1c by ~1.9 to 2.6 percentage points in type 2 diabetes across SURPASS trials
  • Outperformed semaglutide 1.0 mg head-to-head on weight loss and HbA1c in SURPASS-2
  • GI effects (nausea, diarrhea, vomiting) drive most discontinuations and ease with slow titration
  • Lean-mass loss observed in body-composition substudies; resistance training and protein intake mitigate this

Side-by-side

Attribute Spermidine Tirzepatide
Category supplement pharmaceutical
Also known as spermidine trihydrochloride, wheat-germ-extract spermidine Mounjaro, Zepbound, LY3298176
Half-life (hr) 6 120
Typical dose (mg) 1.2 10
Dosing frequency daily, typically morning with food weekly
Routes oral subcutaneous
Onset (hr) 2 24
Peak (hr) 4 72
Molecular weight 145.25 4813.45
Molecular formula C7H19N3 C225H348N48O68
Mechanism Induces macroautophagy via inhibition of EP300 histone acetyltransferase and activation of TFEB-mediated lysosomal biogenesis. Substrate for hypusination of eIF5A, required for translation of mitochondrial respiration proteins. Synthetic 39-amino-acid peptide that activates both GIP and GLP-1 receptors. Potentiates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic and brainstem satiety circuits.
Legal status OTC dietary supplement (wheat-germ extract has GRAS status in US) Prescription only; FDA-approved 2022 (T2DM, Mounjaro) and 2023 (chronic weight management, Zepbound)
WADA status allowed allowed
DEA / Rx OTC supplement (not scheduled) Rx only (not a controlled substance)
Pregnancy Insufficient data; not routinely recommended at supplemental doses Not recommended; discontinue 2 months before planned pregnancy
CAS 124-20-9 2023788-19-2
PubChem CID 1102 156588324
Wikidata Q411089 Q105099794

Safety profile

Spermidine

Common side effects

  • mild GI upset (rare)
  • headache (rare)

Contraindications

  • wheat-germ allergy or celiac disease (for wheat-germ-extract products)
  • active cancer (theoretical)
  • pregnancy and lactation (insufficient data)

Interactions

  • DFMO (difluoromethylornithine): competing polyamine metabolism; do not combine without oncology guidance(moderate)

Tirzepatide

Common side effects

  • nausea
  • diarrhea
  • vomiting
  • constipation
  • decreased appetite
  • injection-site reactions
  • fatigue
  • abdominal pain

Contraindications

  • personal or family history of medullary thyroid carcinoma
  • multiple endocrine neoplasia type 2
  • pregnancy
  • history of pancreatitis (use caution)
  • severe gastroparesis

Interactions

  • insulin: additive hypoglycemia risk; insulin dose typically reduced(major)
  • sulfonylureas (glipizide, glyburide): hypoglycemia risk, sulfonylurea dose often reduced(major)
  • oral medications (general): delayed gastric emptying can alter absorption kinetics(moderate)
  • oral contraceptives: reduced exposure after first dose; backup contraception recommended for 4 weeks after initiation and each dose escalation(moderate)
  • warfarin: monitor INR due to altered absorption(moderate)

Which Should You Take?

Spermidine comes out ahead for most readers on the criteria we weight: 2 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-A outcome catalogued. Tirzepatide is the right call when one of the conditionals below applies.

  • If your priority is healthspan extension, pick Spermidine.
  • If your priority is focus or working memory, pick Spermidine.
  • If your priority is metabolic health and glucose control, pick Tirzepatide.
  • If your priority is fat loss, pick Tirzepatide.

Edge case: If you want to avoid prescription-only, Spermidine is the more accessible choice.

Default choice: Spermidine. Lower friction to source, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Tirzepatide only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Spermidine and Tirzepatide?

Spermidine and Tirzepatide differ in category (supplement vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Spermidine or Tirzepatide?

Spermidine half-life is 6 hours; Tirzepatide half-life is 120 hours.

Can you stack Spermidine with Tirzepatide?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper